Your browser doesn't support javascript.
Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amid the COVID-19 Pandemic: A Cross-sectional Study.
Hull, Mariam; Parnes, Mered; Jankovic, Joseph.
  • Hull M; Section of Pediatric Neurology and Developmental Neuroscience (MH, MP), Texas Children's Hospital and Baylor College of Medicine; and Department of Neurology (MH, MP, JJ), Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX.
  • Parnes M; Section of Pediatric Neurology and Developmental Neuroscience (MH, MP), Texas Children's Hospital and Baylor College of Medicine; and Department of Neurology (MH, MP, JJ), Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX.
  • Jankovic J; Section of Pediatric Neurology and Developmental Neuroscience (MH, MP), Texas Children's Hospital and Baylor College of Medicine; and Department of Neurology (MH, MP, JJ), Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX.
Neurol Clin Pract ; 11(5): e686-e690, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1883568
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Functional (psychogenic) movement disorders (FMDs) are conditions in which affected patients develop abnormal movements that are incongruous with known, organic, movement disorders, often associated with psychological stressors.

METHODS:

In this case series, electronic medical records of all patients who presented to our adult and pediatric tertiary care movement disorders clinics between March 1 and October 30, 2020, and during the same period in 2019 were reviewed. All patients diagnosed with functional (psychogenic) movement disorder were included if they satisfied diagnostic criteria.

RESULTS:

Among 550 new patients referred for evaluation at our tertiary care movement disorders centers, 45 (8.2%) received a diagnosis of FMD; 75.6% were female, in comparison to the prior year during which time 665 new patients were evaluated and 5.1% were diagnosed with FMD. This represents a 60.1% increase (90.1% in pediatric cohort, 50.9% in adult cohort) in new patients diagnosed with FMD during the COVID-19 pandemic.

CONCLUSIONS:

Within our patient population, there has been increased incidence of FMDs in the setting of the COVID-19 pandemic, possibly reflecting increased psychological and other stressors during this period.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Neurol Clin Pract Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Neurol Clin Pract Year: 2021 Document Type: Article